.

Guns N' Roses Hit New Milestone With Reunion Tour

10-20-2017
.
Guns N' Roses

(hennemusic) Guns N' Roses have hit another milestone with their "Not In This Lifetime" reunion tour which has now topped the $400 million mark since its launch in April 2016.

According to the latest figures from Billboard Boxscore, a 19-date summer European leg by the trio of Axl Rose, Slash and Duff McKagan added $112 million in ticket revenue to expand the total take from the extended global trek.

Guns N' Roses launched the 2017 summer shows before a sold-out crowd of 80,000 at Ireland's Slane Castle on May 27. Revenue from the European run adds to the group's summer North American concerts, which saw them play before more than 535,000 fan to take in $53 million at the box office to tip the total past $300 million. Read more here.

hennemusic is an official news provider for antiMusic.com.
Copyright hennemusic - Excerpted here with permission.

Guns N' Roses Music, DVDs, Books and more

Guns N' Roses T-shirts and Posters

More Guns N' Roses News

Share this article

Share on Facebook Share on Twitter Share on Google+ Pin it Share on Reddit email this article


Related Stories


New Axl Rose Song Streaming Online

Guns N' Roses Reunion Offer Turned Down By Former Member 2018 In Review

Reunited Guns N' Roses Want To Make New Music Says Slash 2018 In Review

Guns N' Roses Hit New Milestone With Classic Video 2018 In Review

Guns N' Roses Stream Unreleased Version Of November Rain 2018 In Review

New Guns N' Roses Or New Nirvana Needed Says Tremonti 2018 In Review

Guns N' Roses' Izzy Stradlin Addresses Reunion Absence 2018 In Review

Axl Rose Misrepresented Says Guns N' Roses Star 2018 In Review

Original Guns N' Roses Stars 'Heartbroken' Over Partial Reunion 2018 In Review

Izzy Stradlin Walked Out On Guns N' Roses Reunion 2018 In Review


advertisement




Day In Rock Reports


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic

Copyright© 1998 - 2018 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.